Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 9—September 2012
Letter

blaOXA-181–positive Klebsiella pneumoniae, Singapore

Tse H. KohComments to Author , Delphine Y.H. Cao, Kian S. Chan, Limin Wijaya, Stewart B.G. Low, Mun S. Lam, Eng E. Ooi, and Li-Yang Hsu
Author affiliations: National University of Singapore, Singapore (T.H. Koh, L.-Y. Hsu); Singapore General Hospital, Singapore (T.H. Koh, D.Y.H. Cao, K.S. Chan, L. Wijaya); Mount Alvernia Hospital, Singapore (S.B.G. Low); Mount Elizabeth Medical Centre, Singapore (M.S. Lam); and Duke–National University of Singapore–Graduate Medical School, Singapore (E.E. Ooi)

Main Article

Table

Antimicrobial drug susceptibilities of 3 blaOXA-181–positive Klebsiella pneumoniae isolates, Singapore*

Drug MIC (mg/L)
DB53879_11 DX1083_11 BL21479_11
Ampicillin ≥256 ≥256 ≥256
Amoxicillin/clavulanate ≥256 ≥256 ≥256
Piperacillin/tazobactam ≥256 ≥256 ≥256
Cefuroxime ≥256 ≥256 ≥256
Ceftriaxone ≥32 ≥32 ≥32
Ceftazidime ≥256 ≥256 ≥256
Cefepime ≥256 ≥256 ≥256
Ertapenem ≥32 ≥32 ≥32
Imipenem 16 ≥32 16
Meropenem ≥32 ≥32 ≥32
Doripenem ≥32 ≥32 ≥32
Ciprofloxacin ≥32 ≥32 ≥32
Levofloxacin ≥32 ≥32 ≥32
Gentamicin ≥256 ≥256 ≥256
Amikacin ≥256 ≥256 ≥256
Sulfamethoxazole/trimethoprim ≥32 ≥32 ≥32
Tetracycine ≥256 ≥256 8
Tigecycline 4 4 4
Polymyxin B 0.5 1 4

*OXA-181, oxacillinase-181.

Main Article

Page created: August 17, 2012
Page updated: August 17, 2012
Page reviewed: August 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external